Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis

PURPOSE: To evaluate the safety and efficacy of 0.003% tacrolimus suspension for the treatment of refractory vernal keratoconjunctivitis (VKC). MATERIALS AND METHODS: This prospective study included 40 eyes of 20 patients with severe VKC. After discontinuing all other medications, patients were trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Amri, Abdulrahman Mohammed, Fiorentini, Sandra Flavia, Albarry, Maan A., Bamahfouz, Ashjan Yousef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657154/
https://www.ncbi.nlm.nih.gov/pubmed/29118487
http://dx.doi.org/10.4103/ojo.OJO_232_2014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657154/
https://www.ncbi.nlm.nih.gov/pubmed/29118487
http://dx.doi.org/10.4103/ojo.OJO_232_2014

Ejemplares similares